HUM Add to watchlist $198.37 +2.16 (+1.10%) Last updated: Apr 16, 2026 04:50
52-Week Range
$198.37
$163.11 $198.37 $315.35

Fundamentals Overview

Humana Inc. is near the low of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 20.1 P/B 1.35 P/S 0.18

Intrinsic value (DCF)

+488% upside vs price

Profitability

Net margin 0.9%

Risk (Beta)

0.45 — lower vol

Earnings & growth

EPS $9.87 Rev -0.4% Profit -508.2% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 56% confidence Risk: Lower Volatility — Beta 0.45. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +488% upside vs price · Analyst grade: B+

Pressures (Sell):

Sentiment weakening (3 downgrades) · 3M vs S&P 500: -29% · 3M vs Healthcare sector: -22.2%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$23.92B
P/E (TTM)
20.09
EPS (TTM)
$9.87
Dividend Yield
1.78%
52-Week Range
$163.11 - $315.35
Volume vs Avg
N/A
Beta
0.45

About

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eli...
Sector: Healthcare
Headquarters: US
Employees: 65,680
IPO Date: Dec 1981
Beta: 0.45 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 4, Equal Weight: 9, Hold: 5, In Line: 1, Neutral: 4, Outperform: 3, Overweight: 1, Sector Perform: 1, Sell: 1, Underweight: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $1,166.39; current price is $198.37. That’s a +488% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 20.09
DCF value (model) $1,166.39 (488% upside)
PEG (TTM) N/A
P/B (TTM) 1.35
P/S (TTM) 0.18
P/FCF (TTM) 63.79
Liquidity & enterprise
Current Ratio (TTM) 0.72
Quick Ratio (TTM) 0.72
Cash Ratio (TTM) 0.41
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 0.92%
Gross margin (TTM) 14.54%
Operating margin (TTM) 1.12%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for HUM.

Analyst Sentiment at a Glance

B+ Sentiment Weakening
Buy 4Equal Weight 9Hold 5In Line 1Neutral 4Outperform 3Overweight 1Sector Perform 1Sell 1Underweight 1
1 upgrade, 3 downgrades
Price Target Consensus
Current $198.37
Median $203.50
Consensus $225.93
Low consensus $146.00
High consensus $344.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Truist Securities maintain Hold Hold 2026-04-13
Evercore ISI Group maintain In Line In Line 2026-04-08
Wells Fargo maintain Equal Weight Equal Weight 2026-04-07
Barclays maintain Equal Weight Equal Weight 2026-02-25
Wells Fargo maintain Equal Weight Equal Weight 2026-02-18
Goldman Sachs maintain Sell Sell 2026-02-17
Truist Securities maintain Hold Hold 2026-02-17
TD Cowen maintain Hold Hold 2026-02-13
Jefferies maintain Buy Buy 2026-02-12
Guggenheim maintain Buy Buy 2026-02-12
Cantor Fitzgerald maintain Neutral Neutral 2026-02-12
RBC Capital downgrade Outperform Sector Perform 2026-02-12
UBS maintain Neutral Neutral 2026-02-12
Morgan Stanley downgrade Equal Weight Underweight 2026-02-02
Wells Fargo downgrade Overweight Equal Weight 2026-01-07
Barclays maintain Equal Weight Equal Weight 2026-01-05
Morgan Stanley maintain Equal Weight Equal Weight 2025-12-18
Jefferies upgrade Hold Buy 2025-12-05
Barclays maintain Equal Weight Equal Weight 2025-11-25
Truist Securities maintain Hold Hold 2025-11-10
Deutsche Bank maintain Hold Hold 2025-11-07
B of A Securities maintain Neutral Neutral 2025-10-10
Mizuho maintain Outperform Outperform 2025-10-09
Wells Fargo maintain Overweight Overweight 2025-10-07
Barclays maintain Equal Weight Equal Weight 2025-10-03
Guggenheim maintain Buy Buy 2025-10-03
Bernstein maintain Outperform Outperform 2025-09-05
Barclays maintain Equal Weight Equal Weight 2025-09-05
B of A Securities maintain Neutral Neutral 2025-09-02
RBC Capital maintain Outperform Outperform 2025-08-21